Senior insider sale
Chief Medical Officer at TREVI THERAPEUTICS, INC. — senior position signals high conviction
$125.3K
48K shares
What this filing means
SCIASCIA THOMAS plans to sell 48K shares of TREVI THERAPEUTICS, INC. valued at approximately $125.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/15/2024ACC: 0001972481-24-000198
Officer10% Owner· Chief Medical Officer
Since May 2019
48K
Shares to sell
$125.3K
Approx. market value
48K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Options
Cash
11/25/2014
48KTotal acquired48K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/25/2014 | Options Cash | 48K | — |
| Total | 48K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
48K
Market value
$125.3K
8/15/2024
Total
Units
48K
Value
$125.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/15/2024 | 48K | $125.3K | NASDAQ | Planned |
| Total | 48K | $125.3K | ||